European Union - English - EMA (European Medicines Agency)

virbac s.a. - purified p45 feline leukaemia virus envelope antigen, live feline calicivirus (strain f9), live feline viral rhinotracheitis virus (strain f2), live feline panleucopenia virus - live feline panleucopenia virus / parvovirus + live feline rhinotracheitis virus + live feline calicivirus + inactivated feline leukaemia virus - cats - for active immunisation of cats from eight weeks of age against:feline calicivirosis to reduce clinical signs.feline viral rhinotracheitis to reduce clinical signs and viral excretion.feline panleucopenia to prevent leucopenia and to reduce clinical signs.feline leukaemia to prevent persistent viraemia and clinical signs of the related disease.onset of immunity: 3 weeks after the primary vaccination for the panleucopenia and leukaemia components, and 4 weeks after the primary vaccination for the calicivirus and rhinotracheitis virus components.duration of immunity: one year after the primary vaccination for all components.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - feline calicivirus - inactivated; chlamydophilia felis inactivated; feline panleucopenia virus - inactivated; feline rhinotracheitis virus - inactivated; amphotericin; neomycin; polymyxin b; thiomersal - misc. vaccines or anti sera - feline calicivirus - inactivated vaccine-viral active 0.0 p; chlamydophilia felis inactivated vaccine-viral active 0.0 p; feline panleucopenia virus - inactivated vaccine-viral active 0.0 p; feline rhinotracheitis virus - inactivated vaccine-viral active 0.0 p; amphotericin antibiotic other 1.36 ug/ml; neomycin antibiotic other 12.0 ug/ml; polymyxin b antibiotic other 20.0 iu/ml; thiomersal mercury other 68.0 ug/ml - immunotherapy - cat - over 8 weeks of age - feline calicivirus | feline chlamydia psittaci | feline enteritis | feline rhinotracheitis | vaccine | calicivirus (feline) | enteritis (feline) | equine rotavirus | fcv | feline herpesvirus type 1 | feline infectious enteritis | feline panleucopenia (fp) | fhv-1 | fvr | herpesvirus 1 (feline) | herpesvirus type 1 (feline) | panleucopenia (feline) | rhinotracheitis (feline)

Philippines - English - FDA (Food And Drug Administration)

broadchem philippines biopharma corporation - inactivated feline panleukopenia virus (fpv) , feline calicivirus (fcv) , feline herpesvirus (fhv) vaccine (vet.) - emulsion for injection (sc) - formulation: each dose (1 ml) contains: inactivated feline panleukopenia (fp) virus (fpv-bio 7 strain) .......... <10^3 tcid50 feline calicivirus (fcv) (fcv-bio 8 strain) ...............< 10^5.5 tcido feline herpesvirus (fhv) (fhv-1-bio 9)........<10% tcid50 tcid - median tissue culture infectious dose

Philippines - English - FDA (Food And Drug Administration)

broadchem philippines biopharma corporation - inactivated feline panleukopenia virus (fpv) , feline calicivirus (fcv) , feline herpesvirus (fhv) , rabies virus (rv) vaccine (vet.) - emulsion for injection (sc) - : formulation: each ml (dose) contains: inactivated feline panleukopenia virus (fpv) (fpv-bio 7 strain) ....... > 10^3 tcid50 feline calicivirus (fcv) (fcv-bio 8 strain) ............. > 10^5.5 tcid 50 feline herpesvirus (fhv) (fhv-1-bio 8).............. > 10^5 tcid 50 rabies virus (msv bio 16-vnukovo-32 strain)........... >.1 iu tcid - tissue culture infectious dose iu - international unit

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - feline panleukopenia virus (cu4 virus strain) inactivated, feline calcivirus (255 virus strain) inactivated, feline rhinotracheitis virus (605 virus strain) inactivated, chlamydophila felis (inactivated) (cello strain) - suspension for injection - unknown - inactivated feline panleucopenia virus / parvovirus vaccine + inactivated feline rhinotracheitis vi - feline - immunological - inactivated vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - chlamydophilia felis baker strain - live, attenuated; amphotericin b; neomycin; polymyxin b; thiomersal - misc. vaccines or anti sera - chlamydophilia felis baker strain - live, attenuated vaccine-viral active 0.0 p; amphotericin b antibiotic other 1.6 ug/ml; neomycin antibiotic other 24.0 ug/ml; polymyxin b antibiotic other 30.0 iu/ml; thiomersal mercury other 40.0 ug/ml - immunotherapy - cat - over 8 weeks of age | kitten | young cat - feline chlamydia psittaci

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - amphotericin b; neomycin; polymixin b; feline leukaemia virus - inactivated; thiomersal - misc. vaccines or anti sera - amphotericin b antibiotic active 0.0 undefined; neomycin antibiotic active 0.0 undefined; polymixin b antibiotic active 0.0 undefined; feline leukaemia virus - inactivated vaccine-viral active 0.0 undefined; thiomersal mercury other 0.0 undefined - immunotherapy - cat | cat - queen | cat - tom | kitten - feline leukaemia virus | disease caused by

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - inactivated feline leukaemia virus(felv) subtypes a, b and c - suspension for injection - . - feline leukaemia virus - cats - immunological - inactivated vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - feline leukaemia virus - inactivated - unknown - feline leukaemia virus - inactivated vaccine-viral active 0.0 - active constituent

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunologicals for felidae, - cats - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs.onsets of immunity isone week after primary vaccination course.the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.